{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T05:24:49Z","timestamp":1732339489953,"version":"3.28.0"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,22]]},"DOI":"10.7759\/cureus.74208","type":"journal-article","created":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T10:15:21Z","timestamp":1732270521000},"source":"Crossref","is-referenced-by-count":0,"title":["Diffuse Large B-Cell Lymphoma: Presentation at an Early Age"],"prefix":"10.7759","author":[{"given":"Sandra","family":"Fernandes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2027612","article-title":"Diffuse large B-cell lymphoma","volume":"384","author":"Sehn LH","year":"2021","unstructured":"Sehn LH, Salles G. Diffuse large B-cell lymphoma. N Engl J Med. 2021, 384:842-58. 10.1056\/NEJMra2027612","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/11.suppl_1.S3","article-title":"Lymphoma classification - from controversy to consensus: the REAL and WHO classifications of lymphoid neoplasms","volume":"11","author":"Harris NL","year":"2000","unstructured":"Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J. Lymphoma classification - from controversy to consensus: the REAL and WHO classifications of lymphoid neoplasms. Ann Oncol. 2000, 11:3-10.","journal-title":"Ann Oncol"},{"key":"ref3","article-title":"(Eds)","year":"2017","unstructured":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. WHO Classification of Tumours, Revised 4th Edition. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J (ed): IARC Publications, Lyon, France; 2017. https:\/\/publications.iarc.fr\/Book-And-Report-Series\/Who-Classification-Of-Tumours\/WHO-Classification-Of-Tumours-Of-Ha...."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2008.26.15_suppl.8583","article-title":"Prognostic significance of primary extranodal diffuse large B-cell lymphoma (DLBCL) in patients treated with R-CHOP","volume":"26","author":"Proctor BR","year":"2008","unstructured":"Proctor BR, Hui D, Donaldson J, et al.. Prognostic significance of primary extranodal diffuse large B-cell lymphoma (DLBCL) in patients treated with R-CHOP. J Clin Oncol. 2008, 26:1658. 10.1200\/jco.2008.26.15_suppl.8583","journal-title":"J Clin Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.8.2780","article-title":"New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project","volume":"16","author":"Armitage JO","year":"1998","unstructured":"Armitage JO, Weisenburger DD. New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project. J Clin Oncol. 1998, 16:2780-95. 10.1200\/JCO.1998.16.8.2780","journal-title":"J Clin Oncol"},{"key":"ref6","article-title":"A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project","volume":"89","year":"1997","unstructured":"A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project. Blood. 1997, 89.3909-18.","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-08-038257","article-title":"The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP","volume":"109","author":"Sehn LH","year":"2007","unstructured":"Sehn LH, Berry B, Chhanabhai M, et al.. The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP. Blood. 2007, 109:1857-61. 10.1182\/blood-2006-08-038257","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1182\/ashsap8.chapter23","article-title":"Aggressive non-Hodgkin and Burkitt lymphoma","author":"Rosenthal A","year":"2022","unstructured":"Rosenthal A, Mehta A. Aggressive non-Hodgkin and Burkitt lymphoma. American Society of Hematology Self-Assessment Program. Altman JK, Mandernach MW, Naik RP, Ulrickson M (ed): American Society of Hematology, Washington, DC; 2022. 10.1182\/ashsap8.chapter23"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/319327-diffuse-large-b-cell-lymphoma-presentation-at-an-early-age","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T10:15:24Z","timestamp":1732270524000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/319327-diffuse-large-b-cell-lymphoma-presentation-at-an-early-age"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,22]]},"references-count":8,"URL":"https:\/\/doi.org\/10.7759\/cureus.74208","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,22]]}}}